Ventas Inc banner

Ventas Inc
NYSE:VTR

Watchlist Manager
Ventas Inc Logo
Ventas Inc
NYSE:VTR
Watchlist
Price: 83.54 USD 0.95% Market Closed
Market Cap: $39.2B

Ventas Inc
Investor Relations

Ventas Inc., a titan within the realm of real estate investment trusts (REITs), has established itself as a cornerstone in the healthcare real estate sector. Built upon a foundation of strategic agility and a keen eye for demographic trends, the company adeptly acquires, owns, and manages a diversified portfolio of properties. Ventas primarily focuses on senior housing and healthcare facilities, capitalizing on the increasing demand fueled by an aging population. This concerted focus on highly resilient sectors allows Ventas to generate stable and growing cash flows, driven by long-term leasing agreements with healthcare operators. The strategic configuration of their portfolio, which spans medical office buildings, life science centers, and hospitals, ensures a balance between growth and defensive attributes, enabling the company to navigate economic fluctuations with poise.

The company's revenue model is tightly interwoven with its vast network of tenants, who possess solid credit profiles and operate under long-term, triple-net leases. These leases require tenants to bear the brunt of property operating expenses, cushioning Ventas from financial volatility. Beyond simply collecting rent, Ventas actively engages in portfolio optimization through acquisitions and divestitures, always aiming to align with healthcare industry dynamics. Its astute leadership continually scouts for investment opportunities that deliver value beyond the present, underpinning ventures in emerging segments such as life sciences and outpatient facilities. This forward-thinking approach not only solidifies Ventas's position in an ever-evolving industry but also underscores its commitment to fostering sustainable growth and value creation for its stakeholders.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 6, 2026
AI Summary
Q4 2025

Strong 2025 Results: Ventas delivered 9% normalized FFO per share growth and 15% growth in same-store SHOP NOI, marking its fourth straight year of double-digit SHOP NOI growth.

Record Shareholder Returns: Total shareholder return reached 35% in 2025, far exceeding industry benchmarks and the S&P 500.

Capital Raising & Investments: The company raised $7 billion in capital and closed $2.5 billion in senior housing acquisitions, further expanding its portfolio.

2026 Guidance: Management expects high single-digit normalized FFO per share growth and nearly 10% total company same-store cash NOI growth, led by SHOP.

Dividend Increase: Ventas announced an 8% increase in its quarterly dividend on the back of strong performance and a positive multiyear outlook.

Fifth Year of Double-Digit SHOP Growth: 2026 guidance calls for 13–17% same-store SHOP NOI growth and 270 bps occupancy growth, with 5% RevPAR growth expected.

Demand & Supply Tailwinds: Secular demand from the aging baby boomer population is outpacing new supply, positioning Ventas for continued growth.

Balance Sheet & Leverage: Leverage improved to 5.2x in Q4 2025, the best since 2012, with continued deleveraging expected in 2026.

Key Financials
Normalized FFO per Share
$3.48
Same-Store SHOP NOI Growth
15% (Q4 YoY)
SHOP Occupancy Growth
300 bps YoY (Q4)
SHOP Margin
over 28% (Q4)
SHOP RevPOR Growth
4.7% (Q4 YoY)
Total Shareholder Return
35% (2025)
Enterprise Value
over $50 billion
Annualized NOI (Q4)
$2.5 billion
Annualized SHOP NOI (Q4)
$1.3 billion
Capital Raised
$7 billion (2025)
Senior Housing Acquisitions
$2.5 billion (2025)
Dividend
8% increase (quarterly dividend)
Leverage
5.2x (Q4 2025)
Total Company Same-Store Cash NOI Growth
8% (Q4 YoY)
Net Income per Share (2026 guidance)
$0.57 (midpoint)
OMAR Same-Store NOI Growth
nearly 4% (Q4 YoY)
Outpatient Medical Same-Store NOI Growth
4.5% (Q4 YoY)
Outpatient Medical Occupancy
almost 21% (Q4)
Research Portfolio NOI Growth
30 bps (Q4 YoY)
G&A Expense
Low $150 million range (2026 guidance)
Earnings Call Recording
Other Earnings Calls

Management

Ms. Debra A. Cafaro
Chairman & CEO
No Bio Available
Mr. J. Justin Hutchens
Executive VP of Senior Housing & Chief Investment Officer
No Bio Available
Ms. Carey Shea Roberts J.D.
Executive VP, General Counsel, Corporate Secretary and Ethics & Compliance Officer
No Bio Available
Mr. Gregory R. Liebbe
Senior VP, Chief Accounting Officer & Controller
No Bio Available
Ms. Bhavana Devulapally
Senior VP & Chief Information Officer
No Bio Available
Mr. Edmund M. Brady III
Chief Human Resources Officer & Senior VP
No Bio Available
Mr. T. Richard Riney J.D.
Senior Advisor
No Bio Available
Mr. Brian K. Wood
Chief Tax Officer & Senior VP
No Bio Available
Mr. Christian N. Cummings
Senior Vice President of Asset Management - Seniors Housing
No Bio Available
Mr. Randy Sohanaki
Head of Applications
No Bio Available

Contacts

Address
ILLINOIS
Chicago
353 N Clark St Ste 3300
Contacts
+13126603800.0
www.ventasreit.com